Jeffrey S. Price
Amministratore Delegato presso Octamer, Inc.
Posizioni attive di Jeffrey S. Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Octamer, Inc.
 Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Direttore Finanziario/CFO | - | - | |
Planet Biotechnology, Inc.
 Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Presidente | 01/01/1998 | - |
Storia della carriera di Jeffrey S. Price
Precedenti posizioni note di Jeffrey S. Price
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Cetus Corp. | Direttore Tecnico/Scientifico/R&S | - | - |
PanGenetics BV
 PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Paesi Bassi | 2 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
Settori
| Health Technology | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
PanGenetics BV
PanGenetics BV Miscellaneous Commercial ServicesCommercial Services PanGenetics BV researches and develops antibody-based therapeutic products. It specializes in taking antibodies at the late research stage through to clinical proof of concept. The firm’s advanced programs are PG102, a CD40 antagonist, and PG110, an anti-Nerve Growth Factor antibody for use in chronic pain. The company was founded by Mark de Boer and James W. Larrick in 1995 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
Octamer, Inc.
Octamer, Inc. Pharmaceuticals: MajorHealth Technology Octamer, Inc. develops pharmaceutical products for acquired immunodeficiency syndrome virus and cancer cells. The company was founded on June 13, 1990 and is headquartered in Walnut Creek, CA. | Health Technology |
| Cetus Corp. | Health Technology |
Planet Biotechnology, Inc.
Planet Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Planet Biotechnology, Inc. identifies and develops promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. The company was is headquartered in Hayward, CA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey S. Price
- Esperienza
